215 related articles for article (PubMed ID: 19835352)
1. Rapid discovery of triazolobenzylidene-thiazolopyrimidines (TBTP) as CDC25 phosphatase inhibitors by parallel click chemistry and in situ screening.
Duval R; Kolb S; Braud E; Genest D; Garbay C
J Comb Chem; 2009; 11(6):947-50. PubMed ID: 19835352
[No Abstract] [Full Text] [Related]
2. Development of novel thiazolopyrimidines as CDC25B phosphatase inhibitors.
Kolb S; Mondésert O; Goddard ML; Jullien D; Villoutreix BO; Ducommun B; Garbay C; Braud E
ChemMedChem; 2009 Apr; 4(4):633-48. PubMed ID: 19212959
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of novel bis-thiazolone derivatives as micromolar CDC25 phosphatase inhibitors: effect of dimerisation on phosphatase inhibition.
Sarkis M; Tran DN; Kolb S; Miteva MA; Villoutreix BO; Garbay C; Braud E
Bioorg Med Chem Lett; 2012 Dec; 22(24):7345-50. PubMed ID: 23141909
[TBL] [Abstract][Full Text] [Related]
4. Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors.
Park H; Li M; Choi J; Cho H; Ham SW
Bioorg Med Chem Lett; 2009 Aug; 19(15):4372-5. PubMed ID: 19500977
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationship of aminopyrimidine IKK2 inhibitors.
Bingham AH; Davenport RJ; Fosbeary R; Gowers L; Knight RL; Lowe C; Owen DA; Parry DM; Pitt WR
Bioorg Med Chem Lett; 2008 Jun; 18(12):3622-7. PubMed ID: 18501602
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel Cdc25 phosphatase inhibitors with micromolar activity based on the structure-based virtual screening.
Park H; Bahn YJ; Jung SK; Jeong DG; Lee SH; Seo I; Yoon TS; Kim SJ; Ryu SE
J Med Chem; 2008 Sep; 51(18):5533-41. PubMed ID: 18714978
[TBL] [Abstract][Full Text] [Related]
7. High-throughput discovery of Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitors using click chemistry.
Tan LP; Wu H; Yang PY; Kalesh KA; Zhang X; Hu M; Srinivasan R; Yao SQ
Org Lett; 2009 Nov; 11(22):5102-5. PubMed ID: 19852491
[TBL] [Abstract][Full Text] [Related]
8. Effective Pharmacophore for CDC25 Phosphatases Enzyme Inhibitors: Newly Synthesized Bromothiazolopyrimidine Derivatives.
El-Shahat M; Salama MAM; El-Farargy AF; Ali MM; Ahmed DM
Mini Rev Med Chem; 2021; 21(1):118-131. PubMed ID: 32560601
[TBL] [Abstract][Full Text] [Related]
9. Traceless solid-phase synthesis of 2-aminothiazoles: receptor tyrosine kinase inhibitors with dual selectivity for Tie-2 and VEGFR-2.
Stieber F; Mazitschek R; Soric N; Giannis A; Waldmann H
Angew Chem Int Ed Engl; 2002 Dec; 41(24):4757-61. PubMed ID: 12481350
[No Abstract] [Full Text] [Related]
10. Microtiter plate based chemistry and in situ screening: a useful approach for rapid inhibitor discovery.
Brik A; Wu CY; Wong CH
Org Biomol Chem; 2006 Apr; 4(8):1446-57. PubMed ID: 16604207
[TBL] [Abstract][Full Text] [Related]
11. Rapid assembly and in situ screening of bidentate inhibitors of protein tyrosine phosphatases.
Srinivasan R; Uttamchandani M; Yao SQ
Org Lett; 2006 Feb; 8(4):713-6. PubMed ID: 16468749
[TBL] [Abstract][Full Text] [Related]
12. Generation of 3,8-substituted 1,2,4-triazolopyridines as potent inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1).
Wang H; Robl JA; Hamann LG; Simpkins L; Golla R; Li YX; Seethala R; Zvyaga T; Gordon DA; Li JJ
Bioorg Med Chem Lett; 2011 Jul; 21(14):4146-9. PubMed ID: 21689935
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel non-peptide inhibitors of BACE-1 using virtual high-throughput screening.
Yi Mok N; Chadwick J; Kellett KA; Hooper NM; Johnson AP; Fishwick CW
Bioorg Med Chem Lett; 2009 Dec; 19(23):6770-4. PubMed ID: 19854048
[TBL] [Abstract][Full Text] [Related]
14. Identification of highly potent and selective Cdc25 protein phosphatases inhibitors from miniaturization click-chemistry-based combinatorial libraries.
Jing L; Wu G; Hao X; Olotu FA; Kang D; Chen CH; Lee KH; Soliman MES; Liu X; Song Y; Zhan P
Eur J Med Chem; 2019 Dec; 183():111696. PubMed ID: 31541869
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel isothiazole inhibitors of the TrkA kinase: structure-activity relationship, computer modeling, optimization, and identification of highly potent antagonists.
Lippa B; Morris J; Corbett M; Kwan TA; Noe MC; Snow SL; Gant TG; Mangiaracina M; Coffey HA; Foster B; Knauth EA; Wessel MD
Bioorg Med Chem Lett; 2006 Jul; 16(13):3444-8. PubMed ID: 16632359
[TBL] [Abstract][Full Text] [Related]
16. 4-Methyl-5-phenyl triazoles as selective inhibitors of 11beta-hydroxysteroid dehydrogenase type I.
Zhu Y; Olson SH; Hermanowski-Vosatka A; Mundt S; Shah K; Springer M; Thieringer R; Wright S; Xiao J; Zokian H; Balkovec JM
Bioorg Med Chem Lett; 2008 Jun; 18(11):3405-11. PubMed ID: 18440811
[TBL] [Abstract][Full Text] [Related]
17. Solid phase combinatorial synthesis of benzothiazoles and evaluation of topoisomerase II inhibitory activity.
Choi SJ; Park HJ; Lee SK; Kim SW; Han G; Choo HY
Bioorg Med Chem; 2006 Feb; 14(4):1229-35. PubMed ID: 16242334
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group.
Chen PC; Patil V; Guerrant W; Green P; Oyelere AK
Bioorg Med Chem; 2008 May; 16(9):4839-53. PubMed ID: 18397827
[TBL] [Abstract][Full Text] [Related]
19. Structure-based development of novel triazoles and related thiazolotriazoles as anticancer agents and Cdc25A/B phosphatase inhibitors. Synthesis, in vitro biological evaluation, molecular docking and in silico ADME-T studies.
Rostom SAF; Badr MH; Abd El Razik HA; Ashour HMA
Eur J Med Chem; 2017 Oct; 139():263-279. PubMed ID: 28803043
[TBL] [Abstract][Full Text] [Related]
20. Novel thienopyrimidine and thiazolopyrimidine kinase inhibitors with activity against Tie-2 in vitro and in vivo.
Luke RW; Ballard P; Buttar D; Campbell L; Curwen J; Emery SC; Griffen AM; Hassall L; Hayter BR; Jones CD; McCoull W; Mellor M; Swain ML; Tucker JA
Bioorg Med Chem Lett; 2009 Dec; 19(23):6670-4. PubMed ID: 19854647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]